Exponent Inc. (EXPO) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Exponent Inc.

    NASDAQ: EXPO · Real-Time Price · USD
    69.50
    0.19 (0.27%)
    At close: Sep 26, 2025, 3:59 PM
    69.50
    0.00%
    After-hours: Sep 26, 2025, 04:10 PM EDT

    Exponent Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Jan 3, 2025 Dec 29, 2023 Dec 30, 2022 Dec 31, 2021
    Revenue
    		 558.51M 536.77M 513.29M 466.27M
    Cost of Revenue
    		 416.23M 319.89M 35.08M 278.05M
    Gross Profit
    		 142.28M 177.3M 199.59M 156.8M
    Operating Income
    		 119.56M 111.32M 140.84M 108.93M
    Interest Income
    		 10M 7.15M 2.1M 66K
    Pretax Income
    		 147.37M 135.9M 132.23M 125.84M
    Net Income
    		 109M 100.34M 102.33M 101.2M
    Selling & General & Admin
    		 22.73M 24.44M 287.89M 293.33M
    Research & Development
    		 n/a n/a n/a n/a
    Other Expenses
    		 n/a 81.12M 84.56M 64.01M
    Operating Expenses
    		 22.73M 383.9M 372.45M 357.34M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 438.96M 385.87M 372.45M 325.92M
    Income Tax Expense
    		 38.37M 35.56M 29.9M 24.64M
    Shares Outstanding (Basic)
    		 51.13M 51.15M 51.73M 52.61M
    Shares Outstanding (Diluted)
    		 51.57M 51.63M 52.28M 53.33M
    EPS (Basic)
    		 2.13 1.96 1.98 1.92
    EPS (Diluted)
    		 2.11 1.94 1.96 1.90
    EBITDA
    		 129.25M 120.24M 147.92M 115.41M
    EBIT
    		 119.56M 111.32M 140.84M 108.93M
    Depreciation & Amortization
    		 9.69M 8.92M 7.08M 6.49M

    Add to Watchlist